TCON News and Press, TRACON Pharmaceuticals Inc. From 04/25/23

2023-04-25 09:04:56 ET TRACON Pharmaceuticals ( TCON ) -51% after I-Mab gets favorable ruling in arbitration. Appreciate Holdings ( SFR ) -26% . First Republic Bank ( FRC ) -22% after Q1 earning release . Netcapital ( NCPL ) -22% . T...

SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other li...

Completed Seven Investments in Existing Portfolio Companies Representing $12.9 Million in Funded Loans WOODSIDE, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider...

2023-03-10 06:51:00 ET Cancer-focused biotech Tracon Pharmaceuticals ( NASDAQ: TCON ) has reached an agreement with the hedge fund Opaleye L.P. on March 09 to offer $3M worth of the company’s common stock and pre-funded warrants in a private placement. Per the terms...

2023-03-08 20:00:20 ET TRACON Pharmaceuticals, Inc. (TCON) Q4 2022 Earnings Conference Call March 08, 2023, 16:30 ET Company Participants Charles Theuer - CEO, President & Director Scott Brown - CFO Conference Call Participants Soumit Roy - Jones Rese...

2023-03-08 16:31:59 ET Tracon press release ( NASDAQ: TCON ): Q4 GAAP EPS of -$0.31 in-line. Cash and cash equivalents were $17.4 million at December 31, 2022, compared to $24.1 million at December 31, 2021, and is expected to fund the company into mid-2023. Shares +...

SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other li...

SAN DIEGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other lif...

Completed 12 Investments in New and Existing Portfolio Companies Representing $327 Million in New Commitments and $232.6 Million in Funded Loans Total Loan Commitments and Funded Investments Grew to $2.3 Billion and $1.8 Billion Since Inception WOODSIDE, Calif., Jan. 10, 2023 (GLOBE N...

Penny Stocks To Buy According To Analysts As the stock market continues to become more and more unpredictable, it’s increasingly important for traders to use every available tool. Whether you’re trading penny stocks or higher-priced shares, one of those tools is analyst insi...